Zusammenfassung
Der Keuchhusten bedeutet eine ernste Gefahr vor allem für Säuglinge und Kleinkinder. In den späteren Altersstufen ist er zwar noch recht häufig, langwierig und unangenehm, aber im allgemeinen nicht mehr lebensbedrohlich. Einige Beispiele aus der Mortalitätsund Morbiditätsstatistikmögen die Verhältnisse demonstrieren.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Andersen, E. K.: Serological Studies on H. pertussis, H. para-pertussis and H. bronchisepticus. Preliminary reports. Acta path. microbiol. scand. 30 54 (1952).
Andersen, E.: Biological Standardisation of Pertussis Vaccine. Copenhagen 1958.
Anderson, G., and E. A. North: The Relation of Pertussis Endotoxin to Pertussis Immunity in the Mouse. Aust. J. exp. Biol. med. Sci. 21 1 (1943).
Banerjea, A., and J. Munoz: The Use of Cellulose Column Chromatography for the Purification of the Heat Labile Toxin of Bordetella Pertussis. Fed. Proc. 19 (1,1), 244 (19
Bastin, R.: Über die Behandlung des Keuchhustens. Münch. med. Wschr., 101 37 (1959).
Bell, J. A.: Pertussis Prophylaxis with two Doses of Alum-Precipitated Vaccine. Publ. Hlth Rep. 56 1535 (1941).
Bell, J. A.: Diphtheria Immunization. Use of Alum-Precipitated Mixture of Pertussis-Vaccine and Diphtheria Toxoid. J. Amer. med. Ass. 137 1009 (1948).
Bell, J. A.: Pertussis immunization. Use of two doses of an alum-precipitated mixture of diphtheria toxoid and pertussis vaccine. J. Amer. med. Ass. 137 1276 (1948).
Berg, J. M.:Neurological complications of pertussis. Brit. med. J. 1958/2 24.
Billaudelle, H., H. Lundback, T. Mellbin and B. Vahlquist: Triple vaccine without aluminiumcarrier. Nord. Med. 68 1339 (1962).
Bordet, J., et O. Gengou: Le microbe de la coqueluche. Ann. Inst. Pasteur 20 731 (1906).
Bordet, J., et Sleeswyk: Sérodiagnostic et variabilité des microbes suivant le milieu de culture. Ann. Inst. Pasteur 24 476 (1910).
Brorson, L. O., and B. Vahlquist: Cerebral reactions following triple vaccination. Nord. Med. 68 1340 (1962).
Brown, G. C., et P. L. Kendrick: Réponse sérologique des nourrissons vaccinés simultanément contre la diphthérie, la conqueluche, le tétanos et la poliomyélite, en fonction de la présence d’anticorps spécifiques d’origine maternelle. Rev. Immunol. (Paris) 24 131 (1960).
Budetta, M.: Il problema terapeutico della pertosse. Osservazioni comparative sui risultati ottenuti con diversi antibiotici e chemioterapici: streptomicina, cloramfenicolo, idrazide, spiramicina. Minerva pediat. 11 1396 (1959).
Butler, N.: Immunisation des nouveau-nés pendant les trois premiers mois. Rev. Immunol. (Paris) 24 56 (1960).
Byers, R. K., and F. C. Moll: Encephalopathies following prophylactic pertussis vaccine. Pediatrics 1 437 (1948).
Chevé, J.: Discussion à Cockburn 1958. Rev. Immunol. (Paris) 22 427 (1958).
Chievitz, I., et A.H. Meyer: Recherches sur la coqueluche. (1). Ann. Inst. Pasteur 30 503 (1916).
Cockburn, W. Ch.: Les incidents et les accidents de la vaccination anticoquelucheuse. Rev. Immunol. (Paris) 22 419 (1958).
Cockburn, W. Ch.: Hazards of pertussis vaccination. Proceedings of a Symposium on immunization in childhood. S. 18. Livingstone, Edinburgh and London 1960 a.
— Pertussis vaccination. Proceedings of a Symposium on immunization in childhood. S. 59. Livingstone, Edinburgh and London 1960b.
Cohen, S. M., and M.W. Wheeler: Pertussis Vaccine Prepared with Phase-I Cultures Grown in Fluid Medium. Amer. J. publ. Hlth 36 371 (1946).
Cruickshank, J. C., and G. G. Freeman: Immunising Fractions isolated from Haemophilus pertussis. Lancet 1937 II 567.
Cruickshank, R.: Durée de l’immunité conférée par la vaccination. Rev. Immunol. (Paris) 24 219 (1960).
Debré, R., F. Herzog et J.-Cl. Guérin: Le sérum d’hommes hyperimmunisés dans le traitement de la coqueluche. Arch. franç. Pédiat. 8 501 (1951).
Debré, R., et J. Zourbas: La vaccination anticoquelucheuse prophylactique. Arch. franç. Pédiat. 8 490 (1951).
Debusmann, M.: Die Behandlung des Keuchhustens mit Hyperimmunserum. Kinderärztl. Praxis 29 343 (1961).
Debusmann, M.: Die Behandlung des Keuchhustens mit Hyperimmunserum. II. Teil: Über die Verwendbarkeit von Hyperimmunglobulin vom Pferd. Kinderärztl. Praxis 30 220 (1962).
Dolby, J. M.: The Separation of the Histamine-Sensitizing Factor from the Protective Antigens of Bordetella pertussis. Immunol. 1 328 (1958).
Doull, J. A., G. S. Shibley et al.: Active Immunization against Pertussis. Amer. J. Dis. Child. 58 691 (1939).
Ebel, D.: Zur Therapie des Keuchhustens im 1. Lebensjahr mit spezifischem Hyperimmunserum Arch. Kinderheilk. 161 7 (1960).
Ehrich, W.E., A. Bondi et al.: The Tolerance of Rabbits for the Agglutinogen and the Toxins of Hemophilus pertussis. Amer. J. med. Sci. 204 (4), 530 (1942).
Eichlseder, W.: Erfahrungen bei der Keuchhustenbehandlung mit Chloramphenikol und Pertussis-Hyperimmun-Globulin. Med. Klin. 1749 (1962).
Eldering, G.: A Study of the Antigenic Properties of Hemophilus Pertussis and Related Organisms. II. Protection Tests in Mice. Amer. J. Hyg. 36 294 (1942).
Eldering, G., and P. Kendrick: A Group of Cultures Resembling both Bacillus pertussis bronchisepticus but Identical with Neither. J. Bact. 33 (1), 71 (1937).
Eldering, G.: Some Practical Considerations in B. Pertussis Vaccine Preparation. Amer. J. publ. Hlth 26 506 (1936).
Evans, D. G.: The Production of Pertussis Antitoxin in Rabbits and the Neutralisation of Pertussis, Parapertussis and Bronchiseptica Toxins. J. Path. Bact. 51 49 (1940).
Evans, D. G.: The Protective Properties of Pertussis Antisera in Experimental Infection. J. Path. Bact. 56 49 (1944).
Evans, D. G.: Antigenic Properties of H. pertussis in Relation to Active Immunisation. Lancet 1942 I 529.
Evans, D. G., and H. B. Maitland: The Preparation of the Toxin of H. Pertussis: Its Properties and Relation to Immunity. J. Path. Bact. 45 715 (1937).
Evans, D. G.: The Failure of Whooping Cough Sera to Neutralise Pertussis Toxin. J. Path. Bact. 48 465 (1939).
Evans, D. G., and F.T. Perkins: An Agglutinin-Production Test in the Study of Pertussis Vaccines. J. Path. Bact. 66 479 (1953).
Evans, D. G.: An Improved Method for Testing the Ability of Pertussis Vaccines to Produce Agglutinin. J. Path. Bact. 68 251 (1954).
Evans, D. G.: Tests for Agglutinin Production by Pertussis Protective Antigen, SPA. J. Path. Bact. 69 329 (1955).
Faerber, K.-P.: Allgemeine und örtliche Reaktion bei Mehrfachimpfungen mit Diphtherie-Pertussis-Tetanus und Diphtherie-Tetanus-Adsorbat-Impfstoff der Behringwerke. Mschr. Kinderheilk. 101 477 (1953).
Felton, H. M., and E. W. Flosdorf: Clinical Results with the Use of Agglutinogen from Phase I Hemophilus Pertussis as a Skin Test for Susceptibility to Whooping Cough. J. Pediat. 22 259 (1943).
Felton, H. M.: The Detection of Susceptibility to Whooping Cough. I. Institutional Experiences with the Pertussis Agglutinogen as Skin Test Reagent. J. Pediat. 29 677 (1946).
Felton, H. M., J. Smolens et al.: The Detection of Susceptibility to Whooping Cough. II. Clinical Standardization of the Diagnostic Skin Test Reagent and Its Use in Institutional and in Private Practice. J. Pediat. 29 687 (1946).
Ferguson, J. K. W.: Programme d’immunisation des nourrissons et des enfants au Canada. Rev. Immunol. 24 304 (1960).
Ferry, N. S.: Etiology of Canine Distemper. J. infect. Dis. 8 399 (1911).
Ferry, N. S.: Further Studies on the Bacillus Bronchicanis, the cause of canine distemper. Amer. vet. Res. 41 77 (1912).
Flosdorf, E. W., and A. Bondi et al.: Studies with H. Pertussis. VI. Antigenicity of the Toxins and the Relation to other Cellular Components from the Several Phases. J. Immunol. 42 133 (1941).
Flosdorf, E. W.: Studies with Hemophilus Pertussis. X. Comparative Antigenic Analysis of Bacillus Parapertussis and Hemophilus Pertussis, Phase I, With Consideration. J. Pediat. 21 625 (1942).
Flosdorf, E. W., and T. F. Dozois et al.: Studies with H. Pertussis. V. Agglutinogenic Relationships of the Phases. J. Bact. 41 457 (1941).
Flosdorf, E. W., and H. M. Felton et al.: Intradermal Test for Susceptibility to and Immunization Against Whooping Cough Using Agglutinogen from Phase I H. Pertussis. Amer. J. med. Sci. 206 421 (1943).
Flosdorf, E. W., and A.C. Kimball: Comparison of Various Physical Means of Liberation of the Agglutinogen from H. Pertussis in Phase I. J. Immunol. 39 287 (1940).
Flosdorf, E. W., and A. C. Kimball: Separation of the Phase I Agglutinogen of H. Pertussis from Toxic Components. J. Immunol. 39 475 (1940).
Flosdorf, E. W., et al. Studies on H. Pertussis. I. Liberation by Sonic Vibration of a Soluble Component That Absorbs Phase I Agglutinins. Proc. Soc. exp. Biol. (N. Y.) 41 122 (1939).
Flosdorf, E. W., A. C. McGuiness, A. C. Kimball and J. G. Armstrong: Preparation and essay of hyperimmune human serum. J. Pediat. 19 638 (1941).
Flosdorf, E. W., Studies with H. pertussis. VIII. The Antigenic Structure of H. pertussis and its clinical Significance. Amer. J. Dis. Child. 64 43 (1942).
Freudenstein, H.: Die Wirksamkeitsprüfung von Pertussis-Impfstoffen an der weißen Maus. Behringwerk-Mitt. 42 143 (1962).
Goerke, L. S., P. Roberts, and J. M. Chapman: Neonatal response to DTP-vaccines. Publ. Hlth Rep. 73 511 (1958).
Gordon, J. E., and R.J. Hood: Whooping cough and its epidemiological anomalies. Amer. J. med. Sci. 222 333 (1951).
Halpern, S. R., and D. Halpern: Early whooping cough immunization. J. Pediat. 33 43 (1948).
Hansen, F.: Aktive Immunisierung im Kindesalter. Dtsch. med. Wschr. 1954 432 u. 468.
— Aktive Immunisierung gegen Keuchhusten. Proph. Med. 1955 18.
Hansen, F.: Die Keuchhustenschutzimpfung in H. Spiess: Schutzimpfungen. Stuttgart: G. Thieme 1958.
Hille, H.: Der Einfluß einer „therapeutischen“ Vakzination auf die Entstehung von Keuchhustenkomplikationen. Münch. med. Wschr. 1958 873.
Hink, J. H., and F.F. Johnson: Preparation of an Antigen Mixture from H. Pertussis by Selective Denaturation. J. Immunol. 57 323 (1947).
Hornibrook, J. W.: Cultivation of Phase I H. pertussis in a semisynthetic liquid Medium. Publ. Hlth Rep. 54 (41) 1847 (1939).
Horton, J. M., and A. Standfast: The separation of the protective and agglutinating Antibodies of Haemophilus pertussis (Phase I) rabbit antisera. Int. Congr. Microbiol. Proc. Sixth 2 335 (1953).
Joó, J.: Le calendrier des vaccinations en Hongrie. Rev. Immunol. 24 325 (1960).
Joó, J, and Z. Pusztai et al.: Histamine-sensitizing activity of various pertussis-vaccines. Z. Immun.-Forsch. 121 143 (1961).
Jundell, L.: Hat normales Serum von Erwachsenen einen Wert als Mittel gegen Keuchhusten. Acta paediat. (Stockh.) 7 319 (1928).
Katsampes, C. P., Brooks, A. M. et al.: Toxicity of Washings from Hemophilus pertussis. Proc. Soc. exp. Biol. (N. Y.) 49 615 (1942).
Kaufman, St., and H. B. Bruyn: Pertussis a clinical study. Amer. J. Dis. Child. 99 417 (1960).
Keller, A. E., J. C. Peterson, and P. M. Denson: Opsonocytophagic reaction to whooping cough vaccination. Amer. J. publ. Hlth 32 240 (1942).
Kendrick, P. L.: A Field Study of Alum-Precipitated Combined Pertussis Vaccine and Diphtheria Toxoid for Active Immunization. Amer. J. Hyg. 38 193 (1943).
Kendrick, P. L.: Secondary Familial Attack Rates from Pertussis in Vaccinated and Unvaccinated Children. Amer. J. Hyg. 32 89 (1940).
Kendrick, P. L.: Use of Alum-Treated Pertussis Vaccine, and of Alum-Precipitated Combined Pertussis Vaccine and Diphtheria Toxoid, for Active Immunization. Amer. J. publ. Hlth 32 615 (1942).
Kendrick, P. L., and G. Eldering et al.: Mouse Protection Tests in the Study of Pertussis Vaccine. A Comparative Series Using the Intercerebral Route for Challenge. Amer. J. publ. Hlth 37 (7), 803 (1947).
Kendrick, P. L.: A Study in Active Immunization against Pertussis. Amer. J. Hyg. 29 133 (1939).
Keogh, E. V., and E. A. North: The Haemagglutinin of Haemophilus Pertussis. I. Haemagglutinin as a Protective Antigen in Experimental Murine Pertussis. Austral. J. exp. Biol. med. Sci. 26 315 (1948).
Keogh, E. V., and E. A. North: Haemagglutinins of the Haemophilus Group. Nature 160 63 (1947).
Kind, L. S.: The Altered Reactivity of Mice after Immunization with Hemophilus Pertussis Vaccine. J. Immunol. 70 411 (1953).
Kind, L. S.: Effects of Heat on the Sensitizing and Shocking Properties of Hemophilus Pertussis. J. Immunol. 77 115 (1956).
Kind, L. S.: Sensitivity of Pertussis-Inoculated Mice to Serotonin. Proc. Soc. exp. Biol. (N. Y.) 95 200 (1957).
Klimenko, W. N.: Die Ätiologie des Keuchhustens. Experimenteller Keuchhusten. Zbl. f. Bakt. I. Orig. 48 64 (1909).
Knowelden, J.: Provocation poliomyelitis. Proceedings of a Symposium on immunization in childhood. S. 11. Livingstone, Edinburgh and London 1960.
Köng, E.: Zur Pertussisimpfung und ihren Gegenindikationen. Helv. paediat. Acta, Ser. D. 8 90 (1953).
Köttgen, U.: Keuchhusten-Probleme. Med. Kl. 1962 1633.
Kohn, J. L., and L. W. Wannamaker et al.: The Use of Pertussis Agglutinogen Skin Test During Active Infection with Whooping Cough. J. Pediat. 36 614 (1950).
Krumwiede, C., and L. Mishulow et al.: The Existence of more than one Immunologic Type of B. Pertussis. J. infect. Dis. 32 22 (1923).
Lawson. G.: Immunity Studies in Pertussis. Amer. J. Hyg. 29 119(1939).
McLeod, N.: Inst. Med. Lab. Techn. p. 92 (1944).
Leslie, P. H., and A.D. Gardner: The Phases of Haemophilus pertussis. J. Hyg. 31 423 (1931).
Lévy, E. M.: Titrage des agglutinines chez les sujets vaccinés. Rev. Immunol. (Paris) 20 285 (1958).
Lévy, E. M.: Évolution de l’immunité chez le nouveau-né et le nourrisson. Rev. Immunol. (Paris) 24 31 (1960).
Lippsett, S. M., H. Bloch, J. Miller, F. Stein, and H. L. Lippsett: Immunization of newborn infants with pertussis vaccine. J. Pediat. 42 301 (1953).
Madsen, T.: Whooping Cough. Its Bacteriology, Diagnosis, Prevention and Treatment. Boston med. surg. J. 192 50 (1925).
Madsen, T.: Vaccination against whooping cough J. Amer. med. Ass. 101 187 (1933).
Maitland, H. B., and A. Guérault: Some Surface Components of Haemo-Philus Pertussis: Immunising Antigen, Histamine—Sensitising Factor and Agglutinogen. J. Path. Bact. 76 (1) 257 (1958).
Malkiel, S., and B. J. Hargis: Anaphylactic Shock in the Pertussis-Vaccinated Mouse. J. Allergy 23 352 (1952).
Mallory, F. B., and A. A. Hornor: Pertussis: The Histological Lesion in the Respiratory Tract. J. medical Res. 27 115 (1912).
Malmgren, B.: Pertussis vaccination. Acta paediat. 51 232 (1962).
—, B. Vahlquist, and R. Zetterström: Complications of Immunization. Brit. med. J. 1960 II 1800.
Mande, R.: Données fondamentales pour l’établissement d’un calendrier des vaccinations chez l’enfant. Rev. Immunol. (Paris) 24 255 (1960).
Marie, J., G. Sée et M. Gaiffe: Le traitement actuel de la coqueluche du nourrisson et du petit enfant. Rev. Immunol. (Paris) 22 433 (1958).
Martin du Pan, R.: The vaccination of the newborn, infant against pertussis. J. Pediat. 53 180 (1958).
Masry, F. L. G.: Production, Extraction and Purification of the Haemagglutinin of H. pertussis. J. gen. Microbiol. 7 201 (1952).
Medical Research Council: The prevention of whooping cough by vaccination. Brit. med. J. 1951 I 1463.
— Vaccination against whooping cough. Relation between protection in children and results of laboratory tests. Brit. med. J. 1956 a II 454.
— Poliomyelitis and prophylactic inoculation against diphtheria, whooping-cough and smallpox. Report of the Medical Research Council Committée on Inoculation Procedures and Neurological Lesions. Lancet. 1956 b II 1223.
— Vaccination against whooping-cough. The final report to the Whooping Cough Immunization Committée of the Medical Research Council and the Medical Officers of Health for Battersea and Wandsworth, Bradford, Liverpool and Newcastle. Brit. med. J. 1959 I 994.
Melin, K.-A.: Pertussis immunization in children with convulsive disorders. J. Pediat. 43 652 (1953).
Miller, J. J., H. K. Faber, M.L. Ryan, R. J. Silverberg, and E. Lew: Immunization against pertussis during the first 4 months of life. Pediat. 4 468 (1949).
Miller, J. J., and S. Havard: The Pertussis Agglutinogen Skin Test. Amer. J. Dis. Child. 75 872 (1948).
Mishulow, L., and L. S. Sharpe et al.: Beef-Heart Charcoal Agar for the Preparation of Pertussis-Vaccines. Amer. J. publ. Hlth 43 (11) 1466 (1953).
Moreno-López, M.: El genero Bordetella. Microbiol. esp. 5 177 (1952).
Morris, D., and J. C. McDonald: Failure of hyperimmune gamma globulin to prevent whooping cough. Arch. Dis. Child. 32 236 (1957).
Munoz, J.: Effect of H. pertussis on Sensitivity of Mice to Serotonin. Proc. Soc. exp. Biol. (N. Y.) 95 328 (1957).
Munoz, J. and F. Schuchardt: Studies on the Sensitivity of Mice to Histamine Following Injection on Hemophilus Pertussis. I. Effect of Strain and Age of Mice. J. Allergy 24 330 (1953).
Munoz, J. and F. Schuchardt, et al.: Anaphylaxis in Hemophilus Pertussis-Treated Mice. I. Passive Anaphylaxis with Heterologous Rabbit Antibody. J. Immunol. 80 77 (1958).
National Institute of Health Minimum Requirements: Pertussis Vaccine 1st Revision. Besthesda, May 1, 1953.
Opitz, H.: Umfrage über die Sterblichkeit keuchhustenkranker Kinder. Kinderärztl. Prax. 30. 249 (1962).
Pennell, R. B., and E.H. Thiele: Studies on the Fractionation of Hemophilus Pertussis Extracts. J. Immunol. 66 627 (1951).
Perkins, J. E., and E. L. Stebbins et al.: Field Study of the Prophylactic Value of Pertussis Vaccine. Amer. J. publ. Hlth 32 63 (1942).
Peterson, J. C., and A. Christie: Immunization in the young infant, response to combined vaccines I–IV. Amer. J. Dis. Child. 81 4 (1951).
Pillemer, L.: Adsorption of protective antigen of Hemophilus pertussis on Human red Cell Stromata. Proc. Soc. exp. Biol. (N. Y.) 75 704 (1950).
—, L. Blum and J. H. Lepow: Protective antigen of Haemophilus pertussis. Lancet 1954, I 1257.
Pillemer, L., u. J. I. Bürrell et al.: Abtrennung und immunologische Bestimmung der löslichen Keuchhustenantigene. Science 106 36 (1947).
Pittman, M.: Influence of Sex of Mice on Histamine Sensitivity and Protection against Hemophilus Pertussis. J. infect. Dis. 89 296 (1951).
Pittman, M.: Comparison of the Histamine-Sensitizing Property with the Protective Activity of Pertussis Vaccines for Mice. J. infect. Dis. 89 300 (1951).
Pittman, M.: Variability of the potency of pertussis vaccine in relation to the number of bacteria. J. Pediat. 45 57 (1954).
Pittman, M.: Keuchhusten und seine Bekämpfung durch Keuch-hustenvaccine. J. Wash. Acad. Sci. 46 234 (1956).
Pittman, M.: Variations du pouvoir protecteur des differents vaccins anticoquelucheux. Leur rapport avec la protection de l’être humain. Rev. Immunol. (Paris) 22 308 (1958a).
Pittman, M.: Discussion à Cockburn 1958. Rev. Immunol. (Paris) 22 432 (1958b).
Pittman, M., and F.G. Germuth jr.: Some Quantitative Aspects of Passive Anaphylaxis in Pertussis-Vaccinated Mice. Proc. Soc. exp. Biol. (N. Y.) 87 425 (1954).
Pontecorvo, M.: Vaccins à corps bactériens simples adsorbés dans l’immunisation contre la coqueluche. Rev. Immunol. (Paris) 22 323 (1958).
Pontecorvo, M.: Vaccination du nourrisson contre la poliomyélite, la coqueluche, la diphthérie et le tétanos. Bases épidemiologiques et données expérimentales. Rev. Immunol. (Paris) 24 153 (1960).
Powell, H. M., and C. G. Culbertson et al.: Charcoal Agar Culture Medium for Preparing H.pertussis Vaccine. Publ. Hlth Rep. 66 (11), 346 (1951).
The Prevention of Whooping-Cough by Vaccination. (A Medical Research Council Investigation). Brit. med. J. 1951, I 1463 ff.
Proom, H.: The Immunological Aspects of Experimental Haemophilus Pertussis Infection. J. Path. Bact. 59 165 (1947).
Ramon, G.: A propos du programme d’immunisation dans l’enfance. Rev. Immunol. (Paris) 24 345 (1960).
Robbins, K. C., and L. Pillemer: The Separation of a Protective Antigen From A Toxin-Producing Strain of Hemophilus Pertussis. J. Immunol. 65 393 (1950).
Robbins, K. C., and L. Pillemer: Separation of pertussal toxin. Proc. Soc. exp. Biol. (N. Y.) 74 75 (1950).
Rowatt, E.: The Growth of Bordetella pertussis. A Review. J. gen. Microbiol. 17 297 (1957).
Russo, A., e L. Romani: Rilievi clinico-epidemiologici sulla pertosse. La profilassi immunitaria dell’infanzia nei suoi riflessi medico sociali. Aggiorn. pediat. 12 351 (1961).
Sako, W., W. L. Trenting, S. R. B. Witt and S. S. J. Nichamin: Early immunisation against pertussis with alum precipitated vaccine. J. Amer. med. Ass. 127 379 (1945).
Sant’Agnese, P. A. di: Simultaneous immunization of newborn infants against diphtheria, tetanus and pertussis. Amer. J. publ. Hlth 40 674 (1950).
Santos Bessa, J. dos: Calendrier des vaccinations au Portugal. Rev. Immunol. (Paris) 24 321 (1960).
Sanyal, R. K.: Histamine Sensitivity in Children after Pertussis Infection. Nature 185 537 (1960).
Sarvan, M.: Le problème des vaccinations en Yougoslavie. Rev. Immunol. (Paris) 24 271 (1960).
Sauer, L. W.: Immunization with Bacillus Pertussis Vaccine. J. Amer. med. Ass. 101 1449 (1933).
Sauer, L. W.: The Known and Unknown of Bacillus Pertussis Vaccine. Amer. J. publ. Hlth 25 1226 (1935).
Sauer, L. W.: The Preparation of Bacillus Pertussis Vaccine for Immunization. J. Amer. med. Ass. 102 1471 (1934).
Schmidt, H.: Grundlagen der spez. Therapie. B. Schulz Verlag 1940.
Schweinsberg, H.: Zur Antigenstruktur von Bordetella pertussis. Behringwerk-Mitt. 40 102 (1961.).
Shibley, G. S., and H. Hoelscher: Studies on Whooping Cough. I. Type-Specific (S) and Dissociation (R) Forms of Hemophilus Pertussis. J. exp. Med. 60 403 (1934).
Singer-Brooks, Ch.: Pertussis-Prophylaxis. A Controlled Study. J. Amer. med. Ass. 114 734 (1940).
Smith, T.: Some Bacteriological and Environmental Factors in the Pneumonias of Lower Animals with Special Reference to the Guinea-Pig. J. med. Res. 29 291 (1913).
Smolens, J., and S. Mudd: Agglutinogen of Hemophilus Pertussis, Phase I, for Skin-Testing. J. Immunol. 47 155 (1943).
Sohier, R.: La pratique de la vaccination anticoquelucheuse simple et assiociée. Rev. Immunol. (Paris) 20 337 (1958).
Spiess, H.: Calendrier des vaccinations. Rev. Immunol. (Paris) 24 319 (1960).
Spiller, V., and L.B. Holt: Whooping cough immunization. Clinical follow-up of first Barking field trial, 1955. Brit. med. J. 1959 II 174.
Sprunt, D. H., and D. S. Martin: In vivo neutralization of pertussis toxin with pertussis antitoxin. Amer. J. Path. 19 255 (1943).
Steigmann, A.: Calendrier des vaccinations. Rev. Immunol. (Paris) 24 310 (1960).
Ström, J.: Is universal vaccination against pertussis always justified? Brit. med. J. 1960 II 1184.
Ström, J.: Cerebral and other reactions associated with triple inoculation. Acta paediat. 51 235 (1962).
Syverton, J. T., A. A. Werder et al.: Cortisone and Roentgen Radiation in Combination as Synergistic Agents for Production of Lethal Infections. Proc. Soc. exp. Biol. (N. Y.) 80 123 (1952).
Tasman, A.: Relationship of type of vaccine and method of inoculation to vaccination reactions after immunization against whooping cough, diphtheria and tetanus. Ned. T. Geneesk. 103 1049 (1959).
Thiele, E. H.: Studies on the Hemagglutinin of Hemophilus Pertussis. J. Immunol. 65 627 (1950).
Toomey, J. A., and W. S. Takacs: The Effect of Various Blood Mediums on the Growth Characteristics of H. Pertussis. J. infect. Dis. 62 297 (1938).
Toomey, J. A., and W. S. Takacs: The Morphology of H. Pertussis Grown under Varying Conditions and on Different Mediums. J. infect. Dis. 60 41 (1937).
Toomey, J. A., and K. Ranta et al.: The Phases or Types of H. Pertussis. J. infect. Dis. 57 49 (1935).
Topley and Wilson: Principles of Bact. and Immunity. London: E. Arnold 1955.
Ungar, J.: Agglutination of Red Blood Corpuscles by H. Pertussis. J. Path. Bact. 61 140 (1949).
Ungar, J.: Réponse sérologique à la vaccination anticoquelucheuse chez les enfants. Rev. Immunol. (Paris) 22 293 (1958).
Ungar, J., and P. W. Muggleton et al.: The Type Specificity of Haemophilus Pertussis. J. Hyg. 52 475 (1954).
Vahlquist, B.: Transfert de l’immunité de la mère à l’enfant par la voie transplacentaire et par l’allaitement. Rev. Immunol. (Paris) 24 7 (1960).
Vahlquist, B.: Diskussion zu Ström (1962). Acta paediat. 51 236 (1962).
Verwey, W. F., and Thiele, E. H.: Studies on the Antigenicity of Toxic Extracts of Hemophilus Pertussis. J. Immunol. 61 27 (1949).
Vogt, D.: Über Diphtherie-, Scharlach-, Tetanus-, Pertussis und BCG-Impfung. Mschr. Kinderheilk. 104 289 (1956).
Volk, V. K.: Observations on the safety of multiple antigen preparations. Amer. J. Hyg. 47 53 (1948).
Volk, V. K.: Safety and effectiveness of multiple antigen preparations in a group of free-living children. Am. J. publ. Hlth 39 1299 (1949).
Warburton, M. F., and S. Fisher: The Haemagglutinin of H. pertussis. III. Extraction of the Antigen from the Bacteria and its Stabilization by Adsorption. Aust. J. exp. Biol. med. Sci. 29 265 (1951).
Weinmann, H., H. Baumgartner u. U. Dessin: Über die theoretischen Grundlagen und den Effekt der Keuchhustenbehandlung mit Pertix. Münch. med. Wschr. 1958 1491.
WHO: Diphtheria and Pertussis Vaccination. Report of a Conference of Heads of Laboratories Producing Diphteria and Pertussis Vaccines. Wld Hlth Org. techn. Rep. Ser. No. 61. Genf: World Health Organisation May 1953.
Wittler, R. G.: The L-Form of Haemophilus pertussis. J. gen. Microbiol. 5 1024 (1951).
Wood, M. L.: A Filtrable Toxic Substance in Broth-Cultures of B. pertussis. J. Immunol. 39 (1), 25 (1940).
Zischinsky, H.: Die Behandlung des Keuchhustens. Neue öst. Z. Kinderheilk. 4 158 (1959).
Zourbas, J.: Etude immunologique et épidémiologique de nourrissons immunisés à l’aide de différents vaccins anticoquelucheux simples ou associés (D. T. C.). Rev. Immunol. (Paris) 22 352 (1958a).
Zourbas, J.: Discussion à Cockburn 1958. Rev. Immunol. (Paris) 22 428 (1958b).
Zourbas, J.: Étude immunologique et épidémiologique de nourrissons immunisés, à partir de l’âge de 3 mois, contre la diphthérie, le tétanos et la coqueluche, dans les crèches du département de la Scine. Rev. Immunol. (Paris) 24 100 (1960a).
Zourbas, J.: Propositions pour un calendrier des vaccinations en fonction des conditions épidémiologiques et l’organisation sanitaire de la France. Rev. Immunol. 24 278 (1960b).
Zourbas, J.: Discussion à Cruickshank (1960) Rev. Immunol. 24 252 (1960 c).
—, et J. Chevé: Epidémiologie et prophylaxie de la coqueluche. Rev. Hyg. Méd. soc. 114 (1961).
Editor information
Rights and permissions
Copyright information
© 1965 Springer-Verlag, Berlin/Heidelberg
About this chapter
Cite this chapter
Vogt, D., Engelhardt, H. (1965). Die Keuchhustenschutzimpfung. In: Herrlich, A. (eds) Handbuch der Schutzimpfungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-92897-0_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-92897-0_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-92898-7
Online ISBN: 978-3-642-92897-0
eBook Packages: Springer Book Archive